Advertisement
By treating or preventing infection

Glecaprevir and Pibrentasvir Aid HCV D&#43/R− Kidney Transplants

0
Two studies demonstrate safe transplant of kidneys from deceased donors with HCV infection
Sitagliptin treatment added to standard care is associated with reduced mortality and improved clinical outcomes for patients with type 2 diabetes hospitalized with COVID-19

Sitagliptin May Cut Mortality in T2DM Patients With COVID-19

0
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Lack of knowledge is one of the barriers to use of prone positioning for acute respiratory distress syndrome

Lack of Knowledge Barrier to Prone Positioning Use in ARDS

0
Implementation strategies developed included educational outreach, learning collaborative
Maternal

Maternal Distress in Pregnancy Tied to Childhood Asthma Risk

0
Maternal depression during pregnancy may increase child's risk for asthma at 10 years of age
Exposure to maternal epidural analgesia during vaginal delivery may increase the later risk for autism spectrum disorders for children

Maternal Epidural During Birth Linked to Later Autism in Kids

0
Autism risk seems to increase with longer duration of epidural exposure
Black and Mixed/Other ethnicity are independently associated with greater hospital admission risk due to COVID-19 but are not associated with in-hospital mortality risk

Black Race Tied to COVID-19 Admissions, but Not Deaths

0
In-hospital mortality higher for Asian patients, despite lower risk for hospital admission
Alcohol use decreased

Alcohol Abstinence Increased Among Young Adults From 2002 to 2018

0
However, increase seen in marijuana use, co-use of alcohol and marijuana
Warning letters have been sent to five companies for illegally selling dietary supplements that contain cesium chloride

FDA Warns Companies About Illegal Sales of Dietary Supplements

0
The supplements contain cesium chloride, but no cesium chloride-containing products are FDA-approved
Enrollment in a study testing an experimental antibody therapy against COVID-19 has been paused by independent monitors.

COVID-19 Antibody Treatment Study Paused

0
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
Protective antibodies persist for months in patients who survive serious COVID-19 infections

Immune Responses Long-Lasting After Serious COVID-19

0
IgG levels remain elevated for four months in patients with symptoms lasting for 14 days